|
Echinococcus species (Echinococcosis)
Read the Chapter
Sliding Table of
Contents on the left of the screen
Vignettes
Tappe D, Frosch M.
Rudolf Virchow and the Recognition of Alveolar
Echinococcosis, 1850s. Emerging
Infectious Diseases 2007;13:732-735.
Tappe D.
Emergence of Polycystic Neotropical Echinococcosis.
Emerg Infect Dis 2008;14(2):292-297.
Ebrahimi A, et al.
Whole body bone scintigraphy in osseous hydatosis: a
case report. BMC Musculoskeletal Disorders.
2007;93:1752-1947.
Hegglin D, Deplazes P.
Control strategy for Echinococcus multilocularis.
Emerg Infect Dis. 2008 Oct;14:1626-8.
Review Article:
Craig, PS, McManus, D., Lightowlers M., Chabalgoity, J., Garcia, H.,
Gavidia, C., Gilman, R., Gonzalez, A., Lorca, M., Naquira, C, Nieto, A., and
Schantz, P. Prevention and Control of Cystic Echinococcosis. The LANCET
Infectious Diseases. June 2007; Vol.7; 6: 385-394.
Tables and
Figures
Table 1. Criteria for the Evaluation of Patients with
Cystic Echinococcosis
Table 2.
Patient Response to Albendazole Treatment in
Cystic Echinococcosis
Table
3. Summary of Cyst Responses to Albendazole Treatment in Cystic
Echinococcosi
Table 4.
Effect of Treatment Duration on Albendazole
Efficacy in Cystic Echinococcosis
Table 5. Comparison of Efficacy of Albendazole & Mebendazole
(Global Evaluation)
of
Patient Response
Table 6. Comparison of Efficacy of Albendazole & Mebendazole
(Cyst Evolution)
of
Patient Response
Table 7. Adverse Clinical Events and Fatal Events in Patients
Treated with Albendazole for Various Reasons
Authors
Dominique Angèle Vuitton, MD, PhD,
Isabelle Beurton, M.D.,
Said Harraga, Ph.D. ,
Gilles Paintaud, M.D., Ph.D.
|
www.antimicrobe.org